According to FutureWise analysis, the market for immuno-oncology in 2023 was US$ 101.4 billion and is expected to reach US$ 240 billion by 2031 at a CAGR of 12%. Cancer immunotherapy, commonly referred to as immuno-oncology, represents a groundbreaking approach to cancer treatment that harnesses the body's own immune system to intercept, eliminate, and manage the disease. By enhancing immune...